New Amsterdam Sciences
New Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions specifically oxidative stress (ROS) driven inflammation, with an initial focus on Rheumatoid Arthritis, Infectious Disease and CNS disorders. The company is committed to fighting COVID-19 and developing therapies for various health challenges including animal health, influenza, neurodegenerative disorders, and radiation mitigation. Their mission is to breathe life into a cure by pursuing innovative treatments to enhance patients' lives across multiple areas of development.
Industries
Nr. of Employees
small (1-50)
New Amsterdam Sciences
Products
Rheumatoid arthritis development program
Therapeutic development program targeting rheumatoid arthritis driven by oxidative stress/inflammation.
COVID-19 therapeutic program
Program developing therapeutics intended to treat COVID-19.
Influenza therapeutics and adjuvant program
Development of influenza-directed therapeutics and vaccine adjuvants.
Progressive Supranuclear Palsy (PSP) program
Development of candidate therapies for the orphan neurodegenerative disorder PSP.
Radiomitigator program
Programs developing agents to mitigate radiation therapy side effects and for biodefense use cases.
Animal health therapeutics program
Development and delivery of therapeutics intended for veterinary applications.
Rheumatoid arthritis development program
Therapeutic development program targeting rheumatoid arthritis driven by oxidative stress/inflammation.
COVID-19 therapeutic program
Program developing therapeutics intended to treat COVID-19.
Influenza therapeutics and adjuvant program
Development of influenza-directed therapeutics and vaccine adjuvants.
Progressive Supranuclear Palsy (PSP) program
Development of candidate therapies for the orphan neurodegenerative disorder PSP.
Radiomitigator program
Programs developing agents to mitigate radiation therapy side effects and for biodefense use cases.
Animal health therapeutics program
Development and delivery of therapeutics intended for veterinary applications.
Services
Internal therapeutic research and development programs
In-house R&D programs advancing therapeutic candidates across multiple indications using an anti-inflammatory/ROS-targeted platform.
Internal therapeutic research and development programs
In-house R&D programs advancing therapeutic candidates across multiple indications using an anti-inflammatory/ROS-targeted platform.
Expertise Areas
- Anti-inflammatory drug discovery
- Reactive oxygen species (ROS)–targeted therapeutics
- Infectious disease therapeutics (including COVID-19)
- Influenza therapeutics and adjuvant development
Key Technologies
- ROS-targeted therapeutic platform
- Vaccine adjuvant development
- Radiomitigation agent development
- Preclinical drug discovery and development